Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Perfect!! We have now effectively driven out that

IMO there is no middle ground, either the MMP is worth billions or not a penny. Some may argue that we’ve already collected revenue from the patents and therefore the patents have value, not necessarily true. Revenue collected so far is nothing more than an attempt to circumvent the responsibility a company believes it will face due to the probability (based on it’s own research) that the patents will be validated.

The results we seek will not happen until the USPTO confirms the validity of the patents, its that simple. With a positive USPTO ruling the share price will perform based on projected income in place of the current situation, that is the "possibility of income". We could see noticeable SP improvements due to business deals, revenue recognition in the 10K, but not to the extent that most SHs’ are in this for.

Hope the board schizophrenia issues are resolved soon. LOL

Bluewing

Share
New Message
Please login to post a reply